Alzamend Neuro, Inc.

Nasdaq:ALZN

Pharmaceutical Preparations·ATLANTA, GA

Financials

19 shown

Type	Period	Ended	Filed
10-Q	Q4 2025	10/31/25	12/9/25	→
10-Q	Q3 2025	7/31/25	9/10/25	→
10-K	FY 2025	4/30/25	7/22/25	→
10-Q	Q1 2025	1/31/25	3/10/25	→
10-Q	Q4 2024	10/31/24	12/11/24	→
10-Q	Q3 2024	7/31/24	9/11/24	→
↓

Earnings Releases (8-K)

3 shown

Filed	Period
7/23/25	Q1 FY2026	→
12/12/24	Q3 FY2025	→
3/16/23	Q4 FY2023	→

News (8-K)

63 shown

Filed	Type	Description
3/6/26	Agreement	Entry into a Material Definitive Agreement	→
11/18/25	Other	Other Events	→
10/14/25	Other	Amendments to Articles of Incorporation or Bylaws	→
10/9/25	Other	Unregistered Sales of Equity Securities	→
9/25/25	Other	Unregistered Sales of Equity Securities	→
8/1/25	Other	Unregistered Sales of Equity Securities	→
↓

Prospectuses & Registrations

22 shown

Filed	Form	Description
3/6/26	424B5	424B5	→
4/9/25	424B3	424B3	→
3/27/25	S-1/A	AMENDMENT NO. 1	→
3/13/25	S-3	S-3	→
10/3/24	424B5	424B5	→
7/10/24	424B3	424B3	→
↓

Filing History(370 filings)

TypeDateAccessionPeriodSize

424B5

Mar 6, 2026

0001214659-26-002941

—

894.9 KB

8-K

Mar 6, 2026

0001214659-26-002932

Mar 6, 2026

510.2 KB

DEFA14A

Feb 26, 2026

0001214659-26-002584

—

500.9 KB

DEF 14A

Feb 26, 2026

0001214659-26-002583

Apr 17, 2026

2.4 MB

PRE 14A

Feb 9, 2026

0001214659-26-001345

Apr 17, 2026

730.9 KB

Dec 30, 2025

0001214659-25-018631PRIMARY DOCUMENT

Dec 23, 2025

7.6 KB

Dec 23, 2025

0001214659-25-018437PRIMARY DOCUMENT

Dec 19, 2025

4.8 KB

10-Q

Dec 9, 2025

0001214659-25-017793

Oct 31, 2025

3.7 MB

8-K

Nov 18, 2025

0001214659-25-016885

Nov 18, 2025

187.4 KB

Oct 24, 2025

0001214659-25-015288PRIMARY DOCUMENT

Oct 23, 2025

4.5 KB

8-K

Oct 14, 2025

0001214659-25-014950

Oct 14, 2025

958.5 KB

Oct 10, 2025

0001214659-25-014861PRIMARY DOCUMENT

Oct 8, 2025

18.0 KB

8-K

Oct 9, 2025

0001214659-25-014818

Oct 9, 2025

187.8 KB

Oct 8, 2025

0001214659-25-014752PRIMARY DOCUMENT

Oct 3, 2025

22.5 KB

SCHEDULE 13D/A

Oct 7, 2025

0001214659-25-014750

—

40.1 KB

SCHEDULE 13D/A

Oct 3, 2025

0001214659-25-014630

—

37.6 KB

Oct 3, 2025

0001214659-25-014629PRIMARY DOCUMENT

Oct 1, 2025

20.1 KB

SCHEDULE 13D/A

Sep 30, 2025

0001214659-25-014424

—

40.3 KB

Sep 30, 2025

0001214659-25-014420PRIMARY DOCUMENT

Sep 26, 2025

10.6 KB

SCHEDULE 13D/A

Sep 25, 2025

0001214659-25-014211

—

38.4 KB

Sep 25, 2025

0001214659-25-014210PRIMARY DOCUMENT

Sep 23, 2025

19.6 KB

8-K

Sep 25, 2025

0001214659-25-014200

Sep 25, 2025

187.3 KB

SCHEDULE 13D/A

Sep 23, 2025

0001214659-25-014057

—

36.1 KB

Sep 23, 2025

0001214659-25-014056PRIMARY DOCUMENT

Sep 19, 2025

15.9 KB

Sep 19, 2025

0001214659-25-013976PRIMARY DOCUMENT

Sep 17, 2025

17.5 KB

25 filings shown

Alzamend Neuro, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(370 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/26/26	DEFA14A	DEFA14A	→
2/26/26	DEF 14A	DEF 14A	→
2/9/26	PRE 14A	PRE 14A	→
3/19/25	DEFA14A	DEFA14A	→
3/17/25	DEFA14A	DEFA14A	→
3/13/25	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
12/30/25	4	PRIMARY DOCUMENT	→
12/23/25	4	PRIMARY DOCUMENT	→
10/24/25	4	PRIMARY DOCUMENT	→
10/10/25	4	PRIMARY DOCUMENT	→
10/8/25	4	PRIMARY DOCUMENT	→
10/3/25	4	PRIMARY DOCUMENT	→
↓

Filed	Form	Description
10/7/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
10/3/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
9/30/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
9/25/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
9/23/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
8/1/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
↓